ERK1/2 pro-survival signalling is suppressed by pirtobrutinib in ibrutinib-resistant MYD88-mutated lymphoma cells

M. Munshi, X. Liu, A. Kofides, N. Tsakmaklis, Z. R. Hunter, M. L. Guerrera, A. Canning, J. N. Gustine, S. Liu, J. M. Hatcher, J. Chen, K. Meid, S. Sarosiek, C. A. Flynn, A. R. Branagan, G. von Keudell, L. M. Palomba, J. J. Castillo, G. Yang, S. P. Treon

ERK1/2 pro-survival signalling is suppressed by pirtobrutinib in ibrutinib-resistant MYD88-mutated lymphoma cells

Br J Haematol. 2024;205:1866–1872.